cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"

Affiliations

• ¹ Department of Pathology, Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Ward Building, 3-140, 303 E. Chicago Ave, Chicago, IL, 60611, USA. Daniel.brat@northwestern.edu.
• ² Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
• ³ Department of Neurosurgery, Huntsman Cancer Center, University of Utah, Salt Lake City, UT, USA.
• ⁴ Department of Neurosurgery, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA.
• ⁵ Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
• ⁶ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
• ⁷ Department of Pathology, University of Colorado School of Medicine, Aurora, CO, USA.
• ⁸ Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
• ⁹ Department of Neuropathology, Heinrich Heine University, Düsseldorf, Germany.
• ¹⁰ German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Düsseldorf, Germany.
• ¹¹ Malnati Brain Tumor Institute, Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
• ¹² Department of Neuropathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
• ¹³ Clinical Cooperation Unit Neuropathology, German Cancer Institute (DKFZ), Heidelberg, Germany.
• ¹⁴ Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.